Evercore ISI raised the firm’s price target on Boston Scientific to $81 from $78 and keeps an Outperform rating on the shares in an earnings preview for the MedTech, Life Science Tools and Diagnostics group.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSX:
- M&A News: Boston Scientific (NYSE:BSX) Will Acquire SILK For $1.2B
- Silk Road Medical downgraded to Hold from Buy at Lake Street
- Silk Road Medical to be acquired by Boston Scientific for $27.50 per share
- Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
- Boston Scientific to acquire Silk Road Medical for $27.50 per share